DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019
November 06 2019 - 4:04PM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that
its third quarter 2019 financial results will be released after the
markets close on Wednesday, November 13th. DiaMedica will host a
live conference call on Thursday, November 14th at 7:00 AM
Central Time to discuss its business update and financial
results.
Conference Call details:
Date:
Thursday, November 14, 2019
Time:
7:00 AM CT / 8:00 AM ET
Web access:
https://event.on24.com/wcc/r/2120577/625481B71D93A3177784DC7A779612B0
Dial In:
(844) 557-8483 (domestic)
(825) 312-2381
(international)
Conference ID:
4594493
Interested parties may access the conference call by dialing in
or listening to the simultaneous webcast. Listeners should log on
to the website or dial in 15 minutes prior to the call. The webcast
will remain available for play back on our website, under investor
events and presentations, following the earnings call and for 12
months thereafter. A telephonic replay of the conference call will
be available until November 21, 2019, by dialing (800) 585-8367 (US
Toll Free), (416) 621-4642 (International), replay passcode
4594493.
About DiaMedica Therapeutics Inc. DiaMedica Therapeutics
Inc. is a clinical stage biopharmaceutical company focused on
developing novel treatments for chronic kidney diseases and
neurological disorders. DiaMedica’s shares are listed on The Nasdaq
Capital Market under the trading symbol “DMAC.”
For more information, please visit www.diamedica.com or follow
us on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191106005707/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024